Omnicell, Inc. (OMCL) Discusses Launch of Titan XT Enterprise Platform and Its Impact on Pharmacy Operations Transcript

Kathleen Nemeth
Senior Vice President of Investor Relations

Good afternoon, everyone, and thank you for joining us today. I’m Kathleen Nemeth with Omnicell. It’s my pleasure to be here today with our founder CEO and President; Randall Lipps, as well as our Chief Financial Officer; Baird Bradford; and our Chief Operating Officer, Nnamdi Njoku.

We’re thrilled that you’re able to join us, both here in the room as well as those of you joining us online. We can’t wait to talk to you more about our announcement this — that we made this morning, which is on our IR website at omnicell.com.

Before we start our Q&A, I do want to remind everyone that during the course of the discussion today, we may make forward-looking statements. There is always risks when you’re talking about the future. So we encourage you to read our most recent filings with the SEC, which you can also find on our website.

With that, I’m going to turn it over to Randall for some opening comments, and we’ll start with some Q&A.

Randall Lipps
Founder, Executive Chairman, President & CEO

Thank you, Kathleen. And what an exciting day it is for us here at the company to launch what I’ve termed our third wave of technology in our platform. We originally started with the G Series, original XT Series, and today we launched our third wave called Titan XT. And this is a new enterprise